Cue Health (HLTHQ)
OTHER OTC:HLTHQ
Top Page
No summary available
Positive Factors
Strong Equity Base
A strong equity base provides financial stability and can help the company weather financial challenges, supporting long-term resilience.
Negative Factors
Significant Revenue Decline
A sharp revenue decline indicates potential market challenges and can impact the company's ability to invest in growth and innovation.
Read all positive and negative factors
Positive Factors
Negative Factors
Strong Equity Base
A strong equity base provides financial stability and can help the company weather financial challenges, supporting long-term resilience.
Read all positive factors
Cue Health (HLTHQ) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$159.00
Dividend YieldN/A
Average Volume (3M)N/A
Price to Earnings (P/E)―
Beta (1Y)88.89
Revenue GrowthN/A
EPS GrowthN/A
CountryUS
Employees726
SectorHealthcare
Sector Strength45
IndustryMedical - Devices
Share Statistics
EPS (TTM)N/A
Shares Outstanding159,091,810
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)0.10
Price to Sales (P/S)0.39
P/FCF Ratio-0.16
Enterprise Value/Market Cap-207.23K
Enterprise Value/Revenue-0.46
Enterprise Value/Gross Profit0.59
Enterprise Value/Ebitda0.11
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Cue Health Business Overview & Revenue Model
Company Description
Cue Health Inc. operates as a healthcare technology company. It provides the Cue Health platform that offers individuals and healthcare providers convenient and personalized access to lab-quality diagnostic tests at home and at the point-of-care, ...
How the Company Makes Money
Cue Health generates revenue through the sale of its diagnostic products and services. The company's primary revenue stream comes from the sales of its Cue Health Monitoring System and related test cartridges, which are designed to detect various ...
Cue Health Financial Statement Overview
Summary
Income Statement
Balance Sheet
Cash Flow
| Breakdown | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 64.22M | 483.48M | 618.11M | 22.95M | 6.63M |
| Gross Profit | -62.87M | 153.50M | 341.56M | 8.00M | 6.63M |
| EBITDA | -311.23M | -148.28M | 166.80M | -39.50M | -16.75M |
| Net Income | -373.46M | -194.06M | 33.11M | -47.35M | -20.61M |
Balance Sheet | |||||
| Total Assets | 339.79M | 694.58M | 940.06M | 316.33M | 27.36M |
| Cash, Cash Equivalents and Short-Term Investments | 81.69M | 242.33M | 423.71M | 127.58M | 14.33M |
| Total Debt | 47.94M | 54.99M | 59.50M | 19.81M | 7.25M |
| Total Liabilities | 89.53M | 118.09M | 233.31M | 241.41M | 11.79M |
| Stockholders Equity | 250.25M | 576.49M | 706.75M | 74.92M | 15.57M |
Cash Flow | |||||
| Free Cash Flow | -157.61M | -175.55M | -125.17M | 14.39M | -16.05M |
| Operating Cash Flow | -137.81M | -112.52M | -9.45M | 92.54M | -13.10M |
| Investing Cash Flow | -19.80M | -63.03M | -115.72M | -78.15M | -2.94M |
| Financing Cash Flow | -3.03M | -5.83M | 419.62M | 100.36M | 3.72M |
Cue Health Risk Analysis
Cue Health disclosed 92 risk factors in its most recent earnings report. Cue Health reported the most risks in the "Tech & Innovation" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
Cue Health Peers Comparison
UnderperformOutperform
Sector (51)
HLTHQ
Cue Health
―
―
―
ADTX
Aditxt
0.79
-5,043.53
-99.98%
NCEL
NewcelX
2.26
-12.65
-84.87%
BJDX
Bluejay Diagnostics
1.95
-11.05
-85.00%
TIVC
Tivic Health Systems
1.00
-3.87
-79.49%
VRAX
Virax Biolabs Group Ltd. Class A
0.17
-0.86
-83.11%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―